Thrombocytopenia as a Side Effect of Heparin Therapy and COVID-19 Vaccination: A Review
INTRODUCTION. Both low-molecular-weight and unfractionated heparins are frequently used to prevent and treat COVID-19-associated thrombosis, placing patients at an increased risk of developing heparin-induced thrombocytopenia (HIT) as an adverse reaction. Vaccination has played a key role in combati...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2025-06-01
|
| Series: | Безопасность и риск фармакотерапии |
| Subjects: | |
| Online Access: | https://www.risksafety.ru/jour/article/view/465 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|